Mark Mascolini has been writing about HIV and AIDS since the beginning of the epidemic. Peer-reviewed work he coauthored has appeared in JAIDS, Antiviral Therapy and the Journal of the International AIDS Society.
His work appears regularly on TheBodyPRO.com and the websites of the National AIDS Treatment Advocacy Project (NATAP), AVAC and the Center for AIDS, as well as in Reviews in Antiviral Therapy & Infectious Diseases.
Mascolini has published interviews with scores of leading HIV investigators, including Bernard Branson, Myron Cohen, Kevin DeCock, Anthony Fauci, Robert Grant, David Ho, Daniel Kuritzkes, Joep Lange and Mark Wainberg.
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.
|Long-Acting HIV Treatment: 5 Myths and Realities|
|Two-Drug HIV Treatment Regimens Effective in Latest Studies|
|'Stop Describing, Start Intervening': Can the CDC's New Viral Load Data Help Guide HIV Programs?|
|The Need to Advocate for Fair HIV Drug Prices|
|Significant Interaction Between Once-Weekly Isoniazid/Rifapentine and Daily Dolutegravir: Study Stopped Due to Toxicity|
|Dose Reduction Potential of Nanoparticle ARV Formulations Confirmed in Humans|